CHAL 5 |
| This case study will compare and contrast patentable pharmaceutical subject matter in India and the United States. Specifically, the presentation will focus on the recent case before the Madras High Court in which Novartis has challenged an Indian law that precludes patenting of modifications in known pharmaceuticals. |
|
The Many Faces of CHAL: Where Chemistry Meets the Law
9:00 AM-12:00 PM, Sunday, August 19, 2007 BCEC -- 257B, Oral
Division of Chemistry & the Law |